Preface |
|
xiii | |
Contributors |
|
xv | |
1 Stem Cells and Nanotechnology in Tissue Engineering and Regenerative Medicine |
|
1 | (26) |
|
1.1 A Brief History of Tissue Engineering and Regenerative Medicine, |
|
|
1 | (2) |
|
1.2 Introduction to Stem Cells, |
|
|
3 | (2) |
|
1.3 Tissue Engineering and Regenerative Medicine Strategies, |
|
|
5 | (3) |
|
|
5 | (1) |
|
1.3.2 Tissue Engineering and Biomaterials, |
|
|
6 | (2) |
|
1.3.3 Bioactive Factors in Tissue Engineering, |
|
|
8 | (1) |
|
1.4 Nanotechnology in Regenerative Medicine and Tissue Engineering, |
|
|
8 | (11) |
|
1.4.1 Introduction to Nanotechnology, |
|
|
8 | (1) |
|
1.4.2 Nano-Based Cell Tracking, |
|
|
9 | (1) |
|
|
10 | (1) |
|
|
11 | (6) |
|
1.4.5 Growth Factor Delivery, |
|
|
17 | (2) |
|
|
19 | (1) |
|
|
19 | (1) |
|
|
20 | (7) |
2 Nanofiber Technology for Controlling Stem Cell Functions and Tissue Engineering |
|
27 | (25) |
|
|
27 | (3) |
|
2.2 Fabrication of Nanofibrous Scaffolds by Electrospinning, |
|
|
30 | (2) |
|
2.3 Stem Cells: Type, Origin, and Functionality, |
|
|
32 | (3) |
|
2.3.1 Mesenchymal Stem Cells, |
|
|
33 | (1) |
|
2.3.2 Embryonic Stem Cells, |
|
|
34 | (1) |
|
2.3.3 Induced Pluripotent Stem Cells, |
|
|
34 | (1) |
|
2.4 Stem Cell-Nanofiber Interactions in Regenerative Medicine and Tissue Engineering, |
|
|
35 | (9) |
|
|
35 | (4) |
|
|
39 | (2) |
|
2.4.3 Bone and Cartilage, |
|
|
41 | (2) |
|
|
43 | (1) |
|
|
44 | (1) |
|
|
45 | (1) |
|
|
45 | (7) |
3 Micro- and Nanoengineering Approaches to Developing Gradient Biomaterials Suitable for Interface Tissue Engineering |
|
52 | (28) |
|
|
52 | (2) |
|
3.2 Classification of Gradient Biomaterials, |
|
|
54 | (5) |
|
3.2.1 Physical Gradients, |
|
|
54 | (3) |
|
3.2.2 Chemical Gradients, |
|
|
57 | (1) |
|
3.2.3 Biological Gradients, |
|
|
58 | (1) |
|
3.3 Micro- and Nanoengineering Techniques for Fabricating Gradient Biomaterials, |
|
|
59 | (11) |
|
|
60 | (1) |
|
|
61 | (1) |
|
|
61 | (1) |
|
|
62 | (1) |
|
3.3.5 Solid Free-Form Technology, |
|
|
63 | (1) |
|
|
63 | (1) |
|
|
64 | (2) |
|
3.3.8 Microcontact Printing, |
|
|
66 | (1) |
|
|
67 | (1) |
|
3.3.10 Nanoimprint Lithography, |
|
|
68 | (1) |
|
|
69 | (1) |
|
|
69 | (1) |
|
|
70 | (1) |
|
|
71 | (1) |
|
|
71 | (9) |
4 Microengineered Polymer- and Ceramic-Based Biomaterial Scaffolds: A Topical Review on Design, Processing, and Biocompatibility Properties |
|
80 | (39) |
|
|
80 | (5) |
|
4.2 Dense Hydroxyapatite Versus Porous Hydroxyapatite Scaffold, |
|
|
85 | (1) |
|
4.3 Property Requirement of Porous Scaffold, |
|
|
86 | (2) |
|
4.4 Design Criteria and Critical Issues with Porous Scaffolds for Bone Tissue Engineering, |
|
|
88 | (2) |
|
|
88 | (1) |
|
|
89 | (1) |
|
|
89 | (1) |
|
4.4.4 Mechanical Properties, |
|
|
89 | (1) |
|
|
89 | (1) |
|
|
89 | (1) |
|
4.5 An Exculpation of Porous Scaffolds, |
|
|
90 | (2) |
|
4.6 Overview of Various Processing Techniques of Porous Scaffold, |
|
|
92 | (3) |
|
4.7 Overview of Physicomechanical Properties Evaluation of Porous Scaffold, |
|
|
95 | (9) |
|
4.8 Overview of Biocompatibility Properties: Evaluation of Porous Scaffolds, |
|
|
104 | (3) |
|
|
107 | (2) |
|
|
109 | (1) |
|
|
109 | (1) |
|
|
110 | (9) |
5 Synthetic Enroutes to Engineer Electrospun Scaffolds for Stem Cells and Tissue Regeneration |
|
119 | (23) |
|
|
119 | (6) |
|
5.1.1 Electrospun Nanofibrous Scaffolds for Tissue Engineering, |
|
|
121 | (1) |
|
5.1.2 Electrospun Nanoparticle Incorporated Natural Polymeric Scaffolds, |
|
|
122 | (3) |
|
|
125 | (6) |
|
5.2.1 Chemistry of Cross-Linking, |
|
|
125 | (1) |
|
5.2.2 Elastomeric Scaffolds, |
|
|
126 | (1) |
|
5.2.3 pH Responsive Polymers, |
|
|
127 | (1) |
|
5.2.4 Thermo-Responsive Polymer Fabrication and Engineering, |
|
|
128 | (1) |
|
5.2.5 Modified Electrospinning Processes, |
|
|
129 | (2) |
|
5.3 Novel Nanofibrous Strategies for Stem Cell Regeneration and Differentiation, |
|
|
131 | (4) |
|
|
135 | (1) |
|
|
135 | (1) |
|
|
135 | (7) |
6 Integrating Top-Down and Bottom-Up Scaffolding Tissue Engineering Approach for Bone Regeneration |
|
142 | (17) |
|
|
142 | (1) |
|
6.2 Clinic Needs in Bone Regeneration Fields, |
|
|
143 | (1) |
|
6.3 Bone Regeneration Strategies and Techniques, |
|
|
144 | (7) |
|
6.3.1 Top-Down Tissue Engineering, |
|
|
144 | (3) |
|
6.3.2 Modular Tissue Engineering (Bottom-Up Approach), |
|
|
147 | (3) |
|
6.3.3 Novel Strategy (Integrating Approach), |
|
|
150 | (1) |
|
6.4 Future Direction and Concluding Remarks, |
|
|
151 | (1) |
|
|
151 | (8) |
7 Characterization of the Adhesive Interactions Between Cells and Biomaterials |
|
159 | (24) |
|
|
159 | (1) |
|
7.2 Adhesion Receptors in Native Tissue, |
|
|
160 | (6) |
|
|
160 | (4) |
|
|
164 | (1) |
|
|
165 | (1) |
|
7.3 Optimization of Cellular Adhesion Through Biomaterial Modification, |
|
|
166 | (4) |
|
7.4 Measurement of Cell Adhesion, |
|
|
170 | (4) |
|
|
171 | (2) |
|
|
173 | (1) |
|
7.4.3 Hydrodynamic Shear Stress, |
|
|
173 | (1) |
|
|
174 | (1) |
|
|
175 | (1) |
|
|
175 | (1) |
|
|
175 | (8) |
8 Microfluidic Formation of Cell-Laden Hydrogel Modules for Tissue Engineering |
|
183 | (19) |
|
|
183 | (1) |
|
8.2 Cell-Laden Hydrogel Modules, |
|
|
184 | (5) |
|
8.2.1 Types of Hydrogels, |
|
|
184 | (1) |
|
8.2.2 Microfluidic Devices for Hydrogel Module Production, |
|
|
185 | (4) |
|
8.3 Cell Assay Systems Using Microfluidic Devices, |
|
|
189 | (2) |
|
8.3.1 Microfluidic Devices for Handling Modules, |
|
|
189 | (1) |
|
8.3.2 Cell Analysis Using Microfluidic Devices, |
|
|
190 | (1) |
|
8.4 Implantable Applications, |
|
|
191 | (3) |
|
8.4.1 Cell-Laden Hydrogel Modules for Transplantation, |
|
|
192 | (1) |
|
8.4.2 Implantable Applications of Cell-Laden Hydrogel Modules, |
|
|
192 | (2) |
|
|
194 | (4) |
|
|
194 | (2) |
|
8.5.2 Random Assembly of Microtissue Units, |
|
|
196 | (1) |
|
8.5.3 Controlled Assembly of Microtissue Units, |
|
|
196 | (1) |
|
8.5.4 Macroscopic Assembly of Microtissue Units, |
|
|
197 | (1) |
|
|
198 | (1) |
|
|
198 | (4) |
9 Micro- and Nanospheres for Tissue Engineering |
|
202 | (18) |
|
|
202 | (2) |
|
9.2 Materials Classification of Micro- and Nanospheres, |
|
|
204 | (1) |
|
9.3 Applications of Micro- and Nanospheres in Tissue Engineering, |
|
|
205 | (7) |
|
9.3.1 Micro- and Nanospheres as Delivery Vehicles, |
|
|
205 | (2) |
|
9.3.2 Micro- and Nanospheres as Functional Components to Modify Mechanical Properties of Scaffolds, |
|
|
207 | (2) |
|
9.3.3 Micro- and Nanospheres as Microreactors, |
|
|
209 | (1) |
|
9.3.4 Micro- and Nanospheres as Building Blocks, |
|
|
210 | (2) |
|
|
212 | (1) |
|
|
212 | (1) |
|
|
212 | (8) |
10 Micro- and Nanotechnologies to Engineer Bone Regeneration |
|
220 | (16) |
|
|
220 | (1) |
|
10.2 Nano-Hydroxyapatite Reinforced Scaffolds, |
|
|
221 | (4) |
|
10.3 Biodegradable Polymeric Scaffolds and Nanocomposites, |
|
|
225 | (2) |
|
10.4 Silk Fibers and Scaffolds, |
|
|
227 | (4) |
|
|
231 | (1) |
|
|
231 | (1) |
|
|
232 | (4) |
11 Micro- and Nanotechnology for Vascular Tissue Engineering |
|
236 | (25) |
|
|
236 | (1) |
|
11.2 Conventional Vascular Grafts, |
|
|
237 | (1) |
|
11.3 Tissue-Engineered Vascular Grafts, |
|
|
237 | (1) |
|
11.4 Micro- and Nanotopography in Vascular Tissue Engineering, |
|
|
238 | (3) |
|
11.4.1 Micro- and Nanotopographies to Mimic Native Architecture, |
|
|
238 | (2) |
|
11.4.2 Microengineered Cell Sheets, |
|
|
240 | (1) |
|
|
240 | (1) |
|
11.5 Micro- and Nanofibrous Scaffolds in Vascular Tissue Engineering, |
|
|
241 | (5) |
|
11.5.1 Nanofibrous Scaffolds, |
|
|
241 | (1) |
|
11.5.2 Electrospun Fibers, |
|
|
241 | (1) |
|
11.5.3 Synthetic and Natural Hybrid Nanofibers, |
|
|
242 | (1) |
|
11.5.4 Release from Nanofibers, |
|
|
243 | (1) |
|
11.5.5 Antithrombogenic Nanofibers, |
|
|
244 | (1) |
|
11.5.6 Cell-Adhesive Nanofibers, |
|
|
245 | (1) |
|
11.5.7 Future Work and Conclusion, |
|
|
245 | (1) |
|
11.6 Microvascular Tissue Engineering, |
|
|
246 | (7) |
|
11.6.1 Need for Microvascular Networks in Tissue Engineering, |
|
|
246 | (1) |
|
|
246 | (1) |
|
11.6.3 Microfluidic Hydrogels, |
|
|
247 | (1) |
|
|
248 | (1) |
|
11.6.5 Hybrid or Advanced Approaches, |
|
|
249 | (2) |
|
|
251 | (1) |
|
|
252 | (1) |
|
|
253 | (1) |
|
|
254 | (7) |
12 Application of Stem Cells in Ischemic Heart Disease |
|
261 | (42) |
|
|
261 | (6) |
|
12.1.1 Potential Uses of Human Stem Cells, |
|
|
263 | (1) |
|
12.1.2 Various Sources of Stem Cells, |
|
|
263 | (1) |
|
12.1.3 Unique Properties of Stem Cells, |
|
|
263 | (1) |
|
12.1.4 Stem Cells Can Give Rise to Specialized Cells, |
|
|
264 | (1) |
|
12.1.5 Embryonic Stem Cells, |
|
|
264 | (2) |
|
|
266 | (1) |
|
12.1.7 Limitations and Concerns with Embryonic Stem Cell Transplantation, |
|
|
267 | (1) |
|
12.2 Adult Skeletal Myoblast Cells, |
|
|
267 | (2) |
|
12.2.1 Advantages to Myoblast Transplantation, |
|
|
269 | (1) |
|
12.2.2 Disadvantages with Skeletal Myoblasts, |
|
|
269 | (1) |
|
12.2.3 Further Recommendations, |
|
|
269 | (1) |
|
12.3 Adult Bone Marrow-Derived Stem Cells, |
|
|
269 | (4) |
|
12.3.1 Advantages of Adult Bone Marrow Cell Transplantation, |
|
|
270 | (1) |
|
12.3.2 Limitations and Concerns with Adult Bone Marrow Cell Transplant, |
|
|
270 | (1) |
|
12.3.3 Resident Cardiac Progenitor Cells, |
|
|
271 | (1) |
|
|
271 | (1) |
|
12.3.5 Advantages of Adult Stem Cells, |
|
|
272 | (1) |
|
12.3.6 Limitations of Adult Stem Cells, |
|
|
272 | (1) |
|
12.3.7 Culturing Embryonic Stem Cells in the Laboratory, |
|
|
272 | (1) |
|
|
273 | (1) |
|
12.3.9 Tests Used to Identify Embryonic Stem Cells, |
|
|
273 | (1) |
|
12.3.10 Tests Used in Identifying Adult Stem Cells, |
|
|
273 | (1) |
|
12.4 Type of Stem Cells Used to Treat Cardiac Diseases, |
|
|
273 | (4) |
|
|
275 | (1) |
|
12.4.2 Identification of Stem Cells, |
|
|
275 | (1) |
|
12.4.3 Mechanisms of Action of Stem Cells, |
|
|
275 | (1) |
|
12.4.4 Immunomodulatory Effect of Stem Cells, |
|
|
276 | (1) |
|
|
277 | (5) |
|
12.5.1 Routes of Application, |
|
|
277 | (1) |
|
|
278 | (1) |
|
12.5.3 Using Stem Cells in Clinical Application and to Treat Disease, |
|
|
278 | (2) |
|
12.5.4 Results of Clinical Trials, |
|
|
280 | (1) |
|
12.5.5 Cell Therapy in Acute Myocardial Infarction, |
|
|
280 | (1) |
|
12.5.6 Research with Stem Cells, |
|
|
281 | (1) |
|
12.5.7 Organ and Tissue Regeneration, |
|
|
281 | (1) |
|
12.5.8 Brain Disease Treatment, |
|
|
281 | (1) |
|
12.5.9 Cell Deficiency Therapy, |
|
|
281 | (1) |
|
12.5.10 Blood Disease Treatments, |
|
|
282 | (1) |
|
12.5.11 General Scientific Discovery, |
|
|
282 | (1) |
|
12.5.12 Transplantation and Left Ventricular Devices, |
|
|
282 | (1) |
|
12.6 Other Developing Technologies in Cell Engineering, |
|
|
282 | (11) |
|
|
282 | (1) |
|
12.6.2 Upcoming Techniques in Guidance to Homing of Stem Cell, |
|
|
283 | (4) |
|
12.6.3 Future Perspectives in Myocardial Repair and, Regeneration, |
|
|
287 | (1) |
|
12.6.4 New Method Helps Stem Cells Find Damaged Tissue Better, |
|
|
288 | (2) |
|
12.6.5 Shortcomings in Stem Cell Applications, |
|
|
290 | (1) |
|
12.6.6 Stem Cell Research Controversy, |
|
|
291 | (1) |
|
12.6.7 Problems with Embryonic Stem Cell Research, |
|
|
291 | (1) |
|
12.6.8 Challenges Remain for Stem Cell Therapies, |
|
|
292 | (1) |
|
|
293 | (1) |
|
|
293 | (10) |
Index |
|
303 | |